NC
NERV icon

Nexthera Capital’s Minerva Neurosciences NERV Stock Holding History

Nexthera Capital’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,112
Closed -$4.08M – 45
2017
Q3 		$4.08M Sell
67,112
-4,763
-7% -$273K 1.05% 26
2017
Q2 		$5.09M Sell
71,875
-22,775
-24% -$1.47M 2.22% 18
2017
Q1 		$6.13M Buy
94,650
+33,030
+54% +$2.57M 3.13% 14
2016
Q4 		$5.79M Buy
+61,620
New +$6.29M 3.4% 12
2016
Q3 		– Sell
-13,375
Closed -$1.09M – 35
2016
Q2 		$1.09M Buy
13,375
+9,112
+214% +$579K 0.95% 19
2016
Q1 		$209K Hold
4,263
– – 0.22% 32
2015
Q4 		$207K Buy
+4,263
New +$178K 0.29% 37

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nexthera Capital's NERV Position: Q4 2017 in Review

Nexthera Capital sold out of Minerva Neurosciences (NERV) in Q4 2017, closing a stake of 67,112 shares — an estimated $4.08M sold.

Nexthera Capital first reported a position in NERV in Q4 2015 and held it in 7 quarters. The position peaked at $6.13M in Q1 2017. 67 funds tracked by Wall St. Rank hold NERV as of Q4 2017.

  • Nexthera Capital reported no remaining Minerva Neurosciences position as of Q4 2017 after selling out during the quarter.
  • Nexthera Capital sold 67,112 Minerva Neurosciences shares in Q4 2017, an estimated $4.08M.
  • Nexthera Capital first reported a position in Minerva Neurosciences in Q4 2015 and held it in 7 quarters.
  • Nexthera Capital's Minerva Neurosciences position peaked at $6.13M in Q1 2017.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2017.

Based on Nexthera Capital's 13F filing for Q4 2017, filed 14 Feb 2018.